Integrated BioPharma, Inc. (INBP)
0.185
0.00 (0.00%)
USD |
OTCM |
Sep 23, 16:00
Integrated BioPharma Accounts Receivable (Quarterly) : 3.655M for March 31, 2026
Accounts Receivable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 3.655M |
| December 31, 2025 | 3.592M |
| September 30, 2025 | 3.983M |
| June 30, 2025 | 5.43M |
| March 31, 2025 | 5.08M |
| December 31, 2024 | 4.228M |
| September 30, 2024 | 4.385M |
| June 30, 2024 | 4.668M |
| March 31, 2024 | 4.719M |
| December 31, 2023 | 3.733M |
| September 30, 2023 | 4.172M |
| June 30, 2023 | 4.511M |
| March 31, 2023 | 4.683M |
| December 31, 2022 | 4.509M |
| September 30, 2022 | 3.711M |
| June 30, 2022 | 4.888M |
| March 31, 2022 | 6.17M |
| December 31, 2021 | 5.467M |
| September 30, 2021 | 3.801M |
| June 30, 2021 | 5.776M |
| March 31, 2021 | 6.455M |
| December 31, 2020 | 4.537M |
| September 30, 2020 | 4.855M |
| June 30, 2020 | 5.507M |
| March 31, 2020 | 4.272M |
| Date | Value |
|---|---|
| December 31, 2019 | 4.879M |
| September 30, 2019 | 3.355M |
| June 30, 2019 | 4.439M |
| March 31, 2019 | 4.957M |
| December 31, 2018 | 4.517M |
| September 30, 2018 | 3.381M |
| June 30, 2018 | 3.796M |
| March 31, 2018 | 3.198M |
| December 31, 2017 | 4.595M |
| September 30, 2017 | 2.673M |
| June 30, 2017 | 4.02M |
| March 31, 2017 | 2.706M |
| December 31, 2016 | 4.42M |
| September 30, 2016 | 3.765M |
| June 30, 2016 | 3.135M |
| March 31, 2016 | 3.634M |
| December 31, 2015 | 3.991M |
| September 30, 2015 | 2.803M |
| June 30, 2015 | 2.638M |
| March 31, 2015 | 2.788M |
| December 31, 2014 | 3.385M |
| September 30, 2014 | 2.297M |
| June 30, 2014 | 2.179M |
| March 31, 2014 | 1.94M |
| December 31, 2013 | 2.289M |
Accounts Receivable Definition
Represents change in working capital due to increase or decrease in receivables for the given period.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Receivable (Quarterly) Benchmarks
| Medifast, Inc. | -- |
| BioForce Nanosciences Holdings, Inc. | -- |
| Skinvisible, Inc. | 0.0226M |
| Nevis Brands, Inc. | 0.156M |
| Skinhealth Systems, Inc. | 17.64M |